Department of Cardiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
National Clinical Research Center for Geriatrics Disease, Beijing 100853, China.
Chin Med J (Engl). 2019 Nov 20;132(22):2724-2728. doi: 10.1097/CM9.0000000000000498.
This article aims to present a brief profile of the advances in prevention and treatment of myocardial injury in cancer therapy based on relevant literature or reports.
The data cited in this review were obtained from articles indexed in PubMed and China National Knowledge Internet (CNKI) up to June 2019.
Articles were selected with the following keywords "Anti-cancer therapy," "Myocardial injury," "Breast cancer," "Echocardiography," and "Chemotherapy."
Due to the rapid development of novel cancer therapeutic approaches, the life expectancy of tumor patients has been prolonged continuously. Meanwhile, a large number of studies have found that among patients benefiting from precise management, some medications have exerted direct or indirect side effects on the cardiovascular system, leading to the occurrence of myocardial injury. Because there are many common risk factors between breast cancer and cardiovascular disease, and there is a special anatomical position between breast and heart, the cardiology related to breast cancer patients is relatively unique in onco-cardiology.
Heart function monitoring is critical during anti-cancer therapy so that we can early identify cardiac abnormalities and actively adopt measures to prevent myocardial injury.
本文旨在根据相关文献或报道，简述癌症治疗中心肌损伤的预防和治疗进展。
本综述中引用的数据来自于截至 2019 年 6 月在 PubMed 和中国知网（CNKI）上索引的文章。
选择的文章使用了以下关键词：“抗癌治疗”、“心肌损伤”、“乳腺癌”、“超声心动图”和“化疗”。
由于新型癌症治疗方法的快速发展，肿瘤患者的预期寿命不断延长。同时，大量研究发现，在受益于精准管理的患者中，一些药物对心血管系统产生了直接或间接的副作用，导致心肌损伤的发生。由于乳腺癌和心血管疾病之间有许多共同的危险因素，而且乳房和心脏之间有一个特殊的解剖位置，因此与乳腺癌患者相关的心脏病学在肿瘤心脏病学中具有独特性。
在抗癌治疗过程中，心脏功能监测至关重要，以便我们能够早期识别心脏异常，并积极采取措施预防心肌损伤。
Zotero 插件